MassGeneral Hospital for Children
Pediatric Gastroenterology
Dr. Harland S. Winter, MD
|
|
Give Review
Dr. Harland S. Winter is an expert in the field of Pediatric Gastroenterology. He graduated from David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical university. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. He received 3 awards: "Regional Top Doctor", "Super Doctor" and "Fellow (FACG)". Harland Winter is a published doctor as well. He has 42 publications published. The latest was: Role of percutaneous abscess drainage in the management of young patients with Crohn disease.
Publications
- Exome Sequencing Analysis Reveals Variants in Primary Immunodeficiency Genes in Patients With Very Early Onset Inflammatory Bowel Disease.
- A MicroRNA Signature in Pediatric Ulcerative Colitis: Deregulation of the miR-4284/CXCL5 Pathway in the Intestinal Epithelium.
- High- and Low-Dose Oral Delayed-Release Mesalamine in Children With Mild-to-Moderately Active Ulcerative Colitis.
- Collagenous gastritis: a morphologic and immunohistochemical study of 40 patients.
- DNA methylation-associated colonic mucosal immune and defense responses in treatment-naïve pediatric Ulcerative colitis.
- Value of endoscopic mucosal biopsies in normal-appearing colonic mucosa.
- Fecal Transplant for Recurrent Clostridium difficile Infection in Children With and Without Inflammatory Bowel Disease.
- Oral prucalopride in children with functional constipation.
- B Cells Secrete Eotaxin-1 in Human Inflammatory Bowel Disease.
- The Economics of Health Care Delivery.
- Esomeprazole for the treatment of GERD in infants ages 1-11 months.
- Case records of the Massachusetts General Hospital. Case 27-2011. A 17-year-old boy with Abdominal pain and weight loss.
- Review of the persistence of Gastroesophageal reflux disease in children, adolescents and adults: does Gastroesophageal reflux disease in adults sometimes begin in chi...
- Intestinal disaccharidase activity in patients with autism: Effect of age, gender, and intestinal inflammation.
- Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells.
- Phase I trial of sargramostim in pediatric Crohn's Disease.
- Shortcomings of the inflammatory bowel Disease Serology 7 panel.
- Incidence of stricturing and penetrating complications of Crohn's Disease diagnosed in pediatric patients.
- Intussusception of the appendix causing small bowel obstruction in a patient with cystic fibrosis.
- Drug-induced lupus associated with infliximab and adalimumab in an adolescent with Crohn Disease.
- Presentation of the 2008 NASPGHAN Distinguished Service Award to Richard Colletti, MD.
- Folate concentrations in pediatric patients with newly diagnosed inflammatory bowel Disease.
- Development of extraintestinal manifestations in pediatric patients with inflammatory bowel Disease.
- Inflammatory bowel Disease in African American children compared with other racial/ethnic groups in a multicenter registry.
- Growth hormone treatment for growth failure in pediatric patients with Crohn's Disease.
- Presentation and Disease course in early- compared to later-onset pediatric Crohn's Disease.
- Reduced intracellular T-helper 1 interferon-gamma in blood of newly diagnosed children with Crohn's Disease and age-related changes in Th1/Th2 cytokine profiles.
- Measuring quality of life in pediatric patients with inflammatory bowel Disease: psychometric and clinical characteristics.
- Gender differences in presentation and course of Disease in pediatric patients with Crohn Disease.
- Pharmacokinetics and pharmacodynamics of lansoprazole in children 13 to 24 months old with Gastroesophageal reflux disease.
- Risk factors for initial surgery in pediatric patients with Crohn's Disease.
- Age-specific questionnaires distinguish GERD symptom frequency and severity in infants and young children: development and initial validation.
- Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel Disease consortium.
- Children with early-onset inflammatory bowel Disease (IBD): analysis of a pediatric IBD consortium registry.
- Acid-related disorders from pediatrics to geriatrics: reducing risks and optimizing outcomes.
- Risk of early surgery for Crohn's Disease: implications for early treatment strategies.
- Proton pump inhibitors in pediatrics: relevant pharmacokinetics and pharmacodynamics.
- Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's Disease.
- Research agenda for pediatric gastroenterology, hepatology and nutrition: allergy and immunology. Report of the North American Society for Pediatric Gastroenterology, ...
- Detecting Microbial Dysbiosis Associated with Pediatric Crohn Disease Despite the High Variability of the Gut Microbiota.
- Role of percutaneous abscess drainage in the management of young patients with Crohn Disease.
Schools
David Geffen School Of Medicine At UCLA University Of California Los Angeles
University Of California Los Angeles
Chldns Hospital Med Center Harvard
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
Conditions Treated
- Abdominal Pain
- Esophagitis
- Gastroesophageal Reflux Disease (GERD)
- Pouchitis
- View All
Doctors Specialties
- Pediatric Gastroenterology
Accepted Insurances
Awards
- Regional Top Doctor
- Super Doctor
- Fellow (FACG)
Education
-
Boston Children's Hospital -
UCLA Medical Center -
David Geffen School of Medicine at UCLA
Hospital
-
Boston Children's Hospital -
Massachusetts General Hospital -
Newton-Wellesley Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Christopher J. Moran, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Esther J. Israel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Qian Yuan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcella Radano, MD |
|
|
Dr. Stephen C. Hardy, MD
This Doctor is OpenDoctor Recommended.
|